SEC Form 4 · accession 0000908662-15-000066
ENANTA PHARMACEUTICALS INC · ENTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen Buckley Jr.
Director
Period of report
Feb 18, 2015
Accepted (ET)
Feb 19, 2015 · 4:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001177648
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 18, 2015 | P | 400 | $33.69 | A | 1,400 | D | |
| Common Stock | Feb 19, 2015 | P | 600 | $34.20 | A | 2,000 | D |
Table II — derivative securities
No Table II lines on this filing.